{"cdcTestId":"2013-0232","testcaseName":"Dose # 3 at 24 weeks.  Series complete.","vaccineGroup":"HepB","evaluationTestType":"Age: At Minimum","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-05-04T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2022-05-04T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-07-04T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Hep B, unspecified formulation","cvx":"45","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-05-04T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-07-04T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Hep B, unspecified formulation","cvx":"45","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2018-02-09T12:43:03.206","generalDescription":"This test case describes when dose #3 of the Hep B vaccine is administered at 24 weeks of age, that the series is complete. ","changedInVersion":"1.0","reasonForChange":""}